News – Page 425 – Endpoints News

Merck sues Johns Hopkins for licensing Keytruda patents in secret and in conflict with research collaboration

3 years ago

In cash saving mode, Oncorus cuts trial, staff, lease, and pipeline

3 years ago

CRO startup Vial scores $67M Series B led by General Catalyst

3 years ago

X4 Pharmaceuticals pulls together some positive data results after a rocky year

3 years ago

BioNTech bets on difficult STING field via small molecule pact with a Polish biotech

3 years ago

Updated: Catalent to cut about 600 jobs in Indiana, Maryland and Texas

3 years ago

Jim Wilson biotech iECURE gets fresh $65M to push pediatric liver disease gene therapy into the clinic

3 years ago

Sana, Codexis lay off staff, reshuffle pipeline in bid to focus cell therapy, enzyme engineering work

3 years ago

PhIIb win puts Nimbus one step closer to challenging Bristol Myers in TYK2

3 years ago

Horizon Therapeutics in takeover talks with Amgen, J&J, Sanofi as potential buyers

3 years ago

Eisai’s expanded Alzheimer’s data leave open questions about safety and clinical benefit

3 years ago

Allogene takes the stage in New York to go deep on its off-the-shelf cell therapies — declaring a first for solid ...

3 years ago

Fosun Pharma considers $3.8B sale of Indian drugmaker Gland Pharma — report

3 years ago

UK regulator warns of severe eye reactions following use of Sanofi and Regeneron's Dupixent

3 years ago

Resilience purchases Ohio biomanufacturing site from AstraZeneca

3 years ago

A Supreme Court chill across biosimilar 'skinny' labels could halt billions in Medicare savings

3 years ago

GSK physician survey finds lupus patients at increased risk for organ damage

3 years ago

MarketingRx roundup: Pfizer, BioNTech re-up iHeartRadio holiday sponsorship; WHO renames monkeypox to 'mpox'

3 years ago

Nestlé reconsiders peanut allergy program two years after $2.6B buyout

3 years ago

Twitter disarray continues as pharma advertisers extend pauses and look around for options, but keep tweeting

3 years ago

Ikena Oncology drops an early-stage program as it looks to stretch its cash

3 years ago

Bristol Myers scraps gene therapy deal with uniQure for cardiovascular diseases

3 years ago

Boehringer Ingelheim buys CD38 drug; Merck bets on machine learning in antibody design

3 years ago

Viatris withdraws accelerated approval for topical antimicrobial 24 years later

3 years ago

First page Previous page 422 423 424425426 427 428 Next page Last page